바이오리더스

KR EN

Papers and Patents

이전 버튼 다음버튼
Platform Technology Details Applied/Registered
M.MucoMax® Cervical cancer Stable constant high-manifestation vector for cervical cancer treatment vaccines and recombinant lactic acid bacteria that has been transformed by the vector
Applied
Registered
Muscular dystrophy Cell surface display vector that manifests myostatin and microorganisms that have been transformed by the vector
Registered
Fusion protein surface display vector of Myo-2 peptide composition, and myostatin and microorganisms that have been transformed by the vector
Registered
Manifestation
(Promoter)
New constant, high-manifestation promoter and its purpose of use
Registered
Transporter
(PKV Vector)
Constant high-manifestation vector containing repE rogue genes
Registered
Display Surface display vector using γ-PGA synthetic genes originating from the Bacillus strain and the method of using this to manifest the surfaces of microorganisms of a protein
Registered
H.HumaMax® CIN1 Use of γ-PGA in the treatment of cervical epithelium dysmorphia
Applied
Vaccine adjuvant Immunoadjuvant composition containing γ-PGA and keto acid nanoparticles
Applied
Vaccine containing either γ-PGA-keto acid-sM2HA2 nanoparticles or γ-PGA-keto acid-sM2HA2CTA1 nanoparticles
Applied